SEC Comment Letter 0000000000-23-004057 to Krystal Biotech, Inc. (KRYS) (CIK 0001711279) (KRYS)
Krystal Biotech, Inc. (KRYS) (CIK 0001711279)
Date: April 24, 2023 · CIK: 0001711279 · Accession: 0000000000-23-004057
AI Filing Summary & Sentiment
File numbers found in text: 001-38210
Letter
United States securities and exchange commission logo April 24, 2023 Kathryn A. Romano Chief Accounting Officer Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh, PA 15203 Re:Krystal Biotech, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed Feberuary 27, 2023 File No. 001-38210 Dear Kathryn A. Romano: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 24, 2023
Kathryn A. Romano
Chief Accounting Officer
Krystal Biotech, Inc.
2100 Wharton Street, Suite 701
Pittsburgh, PA 15203
Re:Krystal Biotech, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed Feberuary 27, 2023
File No. 001-38210
Dear Kathryn A. Romano:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences